Ranitidine-Akos

Ranitidine-AKOS: An effective remedy for the treatment of gastrointestinal diseases

Ranitidine-AKOS is a blocker of H2-histamine receptors and a similar drug produced in Russia by the company Sintez AKO. It is widely used to treat various gastrointestinal diseases, such as gastric and duodenal ulcers, reflux esophagitis, Zollinger-Ellison syndrome, chronic dyspepsia and others.

The active ingredient in Ranitidine-AKOS is ranitidine. This is the international name of the drug, which is also known under various synonyms, including Apo-Ranitidine, Asitek, Acidex, Atsilok, Acylok-E, Vero-Ranitidine, Gen-Ranitidine, Gertokalm and others. Ranitidine-AKOS is available in the form of film-coated tablets in strengths of 150 mg and 300 mg.

The use of Ranitidine-AKOS is recommended in the following cases: gastric and duodenal ulcers, NSAID gastropathy, postoperative ulcers, reflux esophagitis, Zollinger-Ellison syndrome, chronic dyspepsia with epigastric and chest pain. The drug can also be used as a prophylaxis for stress ulcers, recurrent bleeding and Mendelssohn's syndrome.

However, there are some contraindications to the use of Ranitidine-AKOS. It is not recommended for patients with hypersensitivity to ranitidine or other components of the drug, as well as in the presence of liver cirrhosis with a history of portosystemic encephalopathy, impaired liver and kidney function, pregnancy, lactation and children under 14 years of age.

Some side effects may occur when using Ranitidine-AKOS, including headache, dizziness, vertigo, drowsiness, anxiety, agitation, depression, hallucinations, blurred vision, involuntary movements, arrhythmias, constipation or diarrhea, nausea, vomiting, abdominal pain, pancreatitis , hepatocellular, cholestatic or mixed hepatitis, arthralgia and myalgia, increased creatinine in the blood, leukopenia, granulocytopenia, thrombocytopenia, agranulocytosis, pancytopenia, bone marrow hypoplasia, Lyell's syndrome, Stevens-Johnson syndrome and others.

It is important to consult with your doctor before starting to take Ranitidine-AKOS to evaluate the indications, contraindications and determine the appropriate dosage. You should strictly follow the recommendations for use specified in the instructions for the drug.

Self-medication and dosage changes without consultation with your doctor are prohibited. If you experience any adverse reactions or problems while taking Ranitidine-AKOS, it is important to seek medical help immediately.

This information is based on knowledge available at the time of model update (September 2021). Always follow the instructions provided by the manufacturer and consult a healthcare professional for the most current information about your specific drug and your medical condition.